Wu et al. reported that GATA6 is frequently silenced by promoter hypermethylation in gastric cancer, and patients with higher GATA6 methylation (indicative of low GATA6 expression) have significantly shorter survival [53]. This evidence concerns the gene GATA6 and gastric cancer.